Neurodegenerative Diseases: Genes, Mechanisms and Therapeutics | EK48

Jun 7, 2021 ‐ Jun 9, 2021



Sessions

Antisense Oligonucleotides for the Treatment of Neurological Diseases

Jun 7, 2021 10:10am ‐ Jun 7, 2021 10:35am

Identification: ek48-48-esym-session-Kordasiewicz-Holly

Speaker(s):

Therapeutic Strategies for the Treatment of Neurodegenerative Disease Based on Human Genetics

Jun 7, 2021 10:35am ‐ Jun 7, 2021 11:00am

Identification: ek48-48-esym-session-Lewcock-Joseph

Speaker(s):

Enhancing Microglia Function with ATV:TREM2

Jun 7, 2021 11:00am ‐ Jun 7, 2021 11:25am

Identification: ek48-48-esym-session-Monroe-Kate

Speaker(s):

Coffee Break iconCoffee Break

Preview Available

Coffee Break

Jun 7, 2021 11:25am ‐ Jun 7, 2021 11:50am

Identification: _esym-session-break-01


Neuroimmunological Target Considerations - To Be or Not To Be in the Brain

Jun 7, 2021 11:50am ‐ Jun 7, 2021 12:15pm

Identification: ek48-48-esym-session-Luthman-Johan

Speaker(s):

Short Talk: TREM2-Independent Neuroprotection Mediated by Monocyte-Derived Macrophages in a Mouse Model of Alzheimer’s Disease

Jun 7, 2021 12:15pm ‐ Jun 7, 2021 12:30pm

Identification: ek48-48-esym-session-Dvir Szternfeld-Raz

Speaker(s):

Short Talk: Myokine Irisin Is a Critical Regulator of Cognitive Function

Jun 7, 2021 12:30pm ‐ Jun 7, 2021 12:45pm

Identification: ek48-48-esym-session-Wrann-Christiane

Speaker(s):

Short Talk: Highly Conserved Glial Pathology and Human-Specific Neuronal Pathology Promote Neurodegeneration in FTLD-GRN

Jun 7, 2021 12:45pm ‐ Jun 7, 2021 1:00pm

Identification: ek48-48-esym-session-Marsan-Elise

Speaker(s):

The Evolving Challenges of Gene Targeted Therapeutics for SMA

Jun 7, 2021 1:00pm ‐ Jun 7, 2021 1:25pm

Identification: ek48-esym-session-Sumner-Charlotte

Speaker(s):

From Therapeutic Targets to Clinic

Jun 7, 2021 1:00pm ‐ Jun 7, 2021 2:30pm

Identification: _esym-session-targets

Co-Chair(s):